Superior Syngeneic Models | SubQperior™ Panel Screen

Why Choose SubQperior™ Panel Screen?

Backed by a Superior Technology

SubQperior™ implantation delivers more homogeneous tumors less prone to ulceration, extending treatment windows and enhancing study reliability.

Diverse Model Selection

Choose from a wide range of syngeneic models, including CT26wt, CloneM3, 4T1, EMT6, MC38-CEA, B16-F10, RENCA, and LL-2, to best suit your study needs.

Flexible Options

Select 6 out of 8 available models to tailor your research according to specific requirements.

Exceptional Value

Pay for one treatment arm and receive data from three, with FREE anti-PD1 and control treatment arms included at no additional cost.

The SubQperior™
Advantage

Subcutaneous implantation of syngeneic models often results in early ulceration, leading to premature study termination, shortened treatment windows, and decreased statistical reliability. Our SubQperior™ tumor models enable tumor growth within a stroma-rich environment by using mammary fat pad injection of the tumor cells. The mammary fat pad acts as a buffer between the tumor and dermis, reducing ulceration and allowing for superior tumor growth compared to traditional subcutaneous methods.